Literature DB >> 26684852

Recent advances in cancer treatment by iron chelators.

Vincent Corcé1, Sébastien G Gouin1, Stéphanie Renaud2, François Gaboriau2, David Deniaud1.   

Abstract

The development of new therapeutic alternatives for cancers is a major public health priority. Among the more promising approaches, the iron depletion strategy based on metal chelation in the tumoral environment has been particularly studied in recent decades. After a short description of the importance of iron for cancer cell proliferation, we will review the different iron chelators developed as potential chemotherapeutics. Finally, the recent efforts to vectorize the chelating agents specifically in the microtumoral environment will be discussed in detail.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  8-Hydroxyquinoline; Iron; Metal chelators; Polyamine; Tumor vectorisation

Mesh:

Substances:

Year:  2015        PMID: 26684852     DOI: 10.1016/j.bmcl.2015.11.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.

Authors:  Pengcheng Li; Xun Zheng; Kangquan Shou; Yahui Niu; Chao Jian; Yong Zhao; Wanrong Yi; Xiang Hu; Aixi Yu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  p53 tumor suppressor and iron homeostasis.

Authors:  Jin Zhang; Xinbin Chen
Journal:  FEBS J       Date:  2018-09-04       Impact factor: 5.542

3.  D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress.

Authors:  Sebastian J Sciegienka; Shane R Solst; Kelly C Falls; Joshua D Schoenfeld; Adrienne R Klinger; Natalie L Ross; Samuel N Rodman; Douglas R Spitz; Melissa A Fath
Journal:  Free Radic Biol Med       Date:  2017-04-05       Impact factor: 7.376

Review 4.  Harnessing microbial iron chelators to develop innovative therapeutic agents.

Authors:  Marta Ribeiro; Cátia A Sousa; Manuel Simões
Journal:  J Adv Res       Date:  2021-11-01       Impact factor: 12.822

5.  Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.

Authors:  Yanru Xue; Gejing Zhang; Shoujie Zhou; Shenghang Wang; Huanhuan Lv; Liangfu Zhou; Peng Shang
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

6.  Proteomic profiling reveals that collismycin A is an iron chelator.

Authors:  Makoto Kawatani; Makoto Muroi; Akira Wada; Gyo Inoue; Yushi Futamura; Harumi Aono; Kenshirou Shimizu; Takeshi Shimizu; Yasuhiro Igarashi; Naoko Takahashi-Ando; Hiroyuki Osada
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

7.  Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1α activation.

Authors:  Ioana Ferecatu; Frédéric Canal; Lucilla Fabbri; Nathalie M Mazure; Cécile Bouton; Marie-Pierre Golinelli-Cohen
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Growth Inhibition of a Novel Iron Chelator, DpdtC, against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy-Mediated Lysosomal ROS Generation.

Authors:  Tengfei Huang; Yanjie Sun; Yongli Li; Tingting Wang; Yun Fu; Cuiping Li; Changzheng Li
Journal:  Oxid Med Cell Longev       Date:  2018-08-05       Impact factor: 6.543

9.  Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators.

Authors:  Gang Cheng; Jacek Zielonka; Micael Hardy; Olivier Ouari; Christopher R Chitambar; Michael B Dwinell; Balaraman Kalyanaraman
Journal:  Oncotarget       Date:  2019-05-28

10.  Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy.

Authors:  Xingshuang Guo; Yun Fu; Zhuo Wang; Tingting Wang; Cuiping Li; Tengfei Huang; Fulian Gao; Changzheng Li
Journal:  Oxid Med Cell Longev       Date:  2018-03-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.